Exploring new pain relief options from Cameroonian plants
From traditional medicine to innovation: Discovering novel analgesics targeting calcium modulation from Cameroonian phytochemicals
This study is exploring new pain relief options made from plants used in traditional Cameroonian medicine, aiming to find natural ways to help people manage chronic pain without using opioids.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-10986264 on NIH RePORTER |
What this research studies
This research investigates the potential of novel compounds derived from traditional Cameroonian plants to provide non-opioid pain relief. By focusing on calcium modulation through a specific protein target, the study aims to isolate and test bioactive compounds that could alleviate chronic pain. The research involves collaboration between institutions in Cameroon and the United States, utilizing both animal models and laboratory assays to evaluate the effectiveness of these compounds. Patients may benefit from innovative pain management solutions that are rooted in traditional medicine.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from chronic pain conditions who are seeking alternative pain relief options.
Not a fit: Patients who do not experience chronic pain or those who are currently managing their pain effectively with existing treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, effective non-opioid analgesics for chronic pain management.
How similar studies have performed: Preliminary studies have shown promising results with similar approaches, indicating potential for success in this novel research.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Tidgewell, Kevin Joseph — University of Kentucky
- Study coordinator: Tidgewell, Kevin Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.